Parachute Health raises a further $9.5mn
Leveraging sophisticated machine learning technology to replace the antiquated process for prescribing orders for Durable Medical Equipment (DME) via fax and paper records, leading health-technology start-up Parachute Health has announced its recent $9.5mn extra in funding, which will enable the business to expand its ePrescribing platform into key markets across the US.
Parachute aims to Improve patient care and reduce costs for payors, providers, and suppliers by dramatically reducing order errors, insurance claim denials and time spent ordering equipment by providing a seamless, all-digital solution, ordering critical medical equipment and services patients need after discharge from hospital - such as oxygen tanks, wheelchairs and medical supplies.
Despite a shift to electronic medical records (EMRs) and years of digital innovation across industries, ordering critical medical supplies for patients still requires fax machines and paper records. More than 80% of fax orders are initially declined due to easily-avoided clerical errors and without electronic delivery confirmation, over 15% of orders are never delivered to patients.
By transforming this outdated legacy process, Parachute has eliminated the need for fax machines, vastly improved patient care, providing significant savings and reduced Medicare fraud and waste related to medical equipment orders.
By fully integrating into most popular EMR systems, such as Epic, Parachute delivers an intuitive, user-friendly solution for medical staff. Its technology is already being used by leading healthcare facilities across the US, including the Hospital for Special Surgery, Visiting Nurse Service of New York and Stanford Hospital, amongst others.
- Tackling the demands of a digital world in an analogue healthcare industry
- Consolidation is enabling healthcare companies to further scale and remain competitive
- AI will work to deliver over $50mn in healthcare savings by 2021
“We are incredibly encouraged by the tremendous interest we’ve seen so far from healthcare facilities and suppliers across the country,” commented Parachute CEO and founder David Gelbard.
“Parachute’s goal is to solve the flaws of the post-acute care industry and to help people who depend on essential at-home equipment and services to live independent and happy lives.”
“Insight saw Parachute’s ability to tap into an area in healthcare where technology was lacking and not only innovate, but also create real change,” said Peter Segall, Managing Director at Insight Venture Partners.
“Investing in healthcare companies that radically improve the system can mean a better quality of life for people.”
The new funding round was led by Harley Miller and Dan Ahrens of Insight Venture Partners and includes investments from GNYHA Ventures, the business arm of the Greater New York Hospital Association and Anthony Welters, formerly of UnitedHealth Group. Parachute previously raised $5.5mn million in funding from investors.
In addition, Parachute is also appointing several new members to the company’s Board of Directors, including Anthony Welters (Former EVP, United Health Group), Lee Perlman (President, GNYHA Ventures) and Peter Segall (Managing Director, Insight Venture Partners). Fred Browne, the former President of McKesson Extended Care, also serves as an advisor to the company.
Data de-identification - why it matters in healthcare
Large amounts of healthcare data is generated yet goes unused due to privacy concerns. To address this, data privacy firm TripleBlind has created Blind De-identification, a new approach that allows healthcare organisations to use patient data while eliminating the possibility of the user learning anything about the patient’s identity.
We asked Riddhiman Das, co-founder and CEO to tell us more about data de-identification.
Why is data de-identification important in healthcare?
Blind De-identification allows every attribute of any given dataset to be used, even at an individual level, while being compliant to privacy laws, rules, and regulations by default.
Governments around the world are adopting global data privacy and residency laws like GDPR, which prohibit citizens’ personally identifiable information data from leaving the borders of the country. While great for data protection, data residency laws result in global silos of inaccessible data. TripleBlind allows computations to be done on enterprise-wise global data, while enforcing data residency regulations.
In the US, HIPAA compliance has relied on what is called the Safe Harbor method, which requires removing 18 types of personal patient identifiers like names, email addresses, and medical record numbers. The Safe Harbor method can be too restrictive with the data or can leave too many indirect identifiers, which puts the patient data security at risk. Getting de-identification wrong could make an organisation liable for a costly mistake.
What does TripleBlind's solution do?
With TripleBlind, data is legally de-identified in real time with practically 0% probability of re-identification. Our solution allows analytics on data containing personally identifiable information and protected health information with zero possibility of re-identifying an individual from the dataset. This allows healthcare organisations to access more meaningful data, creating more accurate and less biased results.
For example, a healthcare drug researcher in a rural, predominantly white area, would only have patient data that would reflect their local population. With TripleBlind’s de-identification, they could more easily leverage third-party data from another healthcare facility in a more diverse region, creating a more complete data set that more accurately reflects the larger population. This has the possibility to create more accurate diagnoses and better drug results for more diverse populations.
How can healthcare organisations use this in practice?
TripleBlind is blind to all data and algorithms. That means we never take possession of customer data. We only route traffic between entities, enforce permissions, and provide audit trails. The enterprise’s data remains under their control. TripleBlind does not host, copy or control their data, algorithms or other information assets, ever.
We facilitate a connection to an encrypted version of their information assets. Our technology allows the algorithms and data to interact in an encrypted space that only exists for the duration of the operation. Organisations use their existing infrastructure, so it’s not hardware dependent.